Lille (France), Cambridge (Massachusetts, United States), September 20, 2017 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at the forefront of developing therapeutic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results